{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:51:39Z","timestamp":1775800299558,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:00:00Z","timestamp":1793836800000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","award":["2025-6-5"],"award-info":[{"award-number":["2025-6-5"]}],"id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","award":["2022-7-1"],"award-info":[{"award-number":["2022-7-1"]}],"id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","award":["2020-6-6"],"award-info":[{"award-number":["2020-6-6"]}],"id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","award":["2017-8-1"],"award-info":[{"award-number":["2017-8-1"]}],"id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K11297"],"award-info":[{"award-number":["25K11297"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K09296"],"award-info":[{"award-number":["24K09296"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08732"],"award-info":[{"award-number":["23K08732"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06854"],"award-info":[{"award-number":["21K06854"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011326","name":"Shiga University of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117484","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:00:39Z","timestamp":1761930039000},"page":"117484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Suppression of the neutrophil-derived S100A8\/A9 complex ameliorates doxorubicin-induced cardiomyopathy in non-human primates"],"prefix":"10.1016","volume":"243","author":[{"given":"Fumiya","family":"Sawasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1979-3921","authenticated-orcid":false,"given":"Akira","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoma","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iori","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issa","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Okuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Ema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-1668","authenticated-orcid":false,"given":"Hisakazu","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2025.117484_b0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2025.117484_b0010","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2025.117484_b0015","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity","author":"Ghigo","year":"2016","journal-title":"Biochim Biophys Acta 1863(7 Pt b)"},{"issue":"5669","key":"10.1016\/j.bcp.2025.117484_b0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/bmj.3.5669.503","article-title":"Clinical evaluation of adriamycin, a new antitumour antibiotic","volume":"3","author":"Bonadonna","year":"1969","journal-title":"Br. Med. J."},{"issue":"11","key":"10.1016\/j.bcp.2025.117484_b0025","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2025.117484_b0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1006\/jmcc.1994.1136","article-title":"Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity","volume":"26","author":"Voest","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2025.117484_b0035","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/1471-2407-14-842","article-title":"Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms","volume":"14","author":"Deng","year":"2014","journal-title":"BMC Cancer"},{"issue":"36","key":"10.1016\/j.bcp.2025.117484_b0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117396119","article-title":"Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy","volume":"119","author":"Ta","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"758","key":"10.1016\/j.bcp.2025.117484_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn8017","article-title":"Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis","volume":"15","author":"Abe","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bcp.2025.117484_b0050","first-page":"17","article-title":"Doxorubicin induced heart failure: Phenotype and molecular mechanisms","volume":"10","author":"Mitry","year":"2016","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"26","key":"10.1016\/j.bcp.2025.117484_b0055","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","article-title":"Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer","volume":"332","author":"Lipshultz","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117484_b0060","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/vcp.13094","article-title":"Age- and sex-related changes in body weights and clinical pathology analytes in cynomolgus monkeys (Macaca Fascicularis) of Mauritius origin","volume":"51","author":"Li","year":"2022","journal-title":"Vet. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jmp.12622","article-title":"Biology and postnatal development of organ systems of cynomolgus monkeys (Macaca fascicularis)","volume":"52","author":"Li","year":"2023","journal-title":"J. Med. Primatol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajco.13776","article-title":"Population pharmacokinetics of doxorubicin: a systematic review","volume":"19","author":"Methaneethorn","year":"2023","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117484_b0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/pharmaceutics14020254","article-title":"Encapsulation, release, and cytotoxicity of doxorubicin loaded in liposomes, micelles, and metal-organic frameworks: a review","volume":"14","author":"Ibrahim","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.bcp.2025.117484_b0080","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","article-title":"Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides","volume":"7","author":"Bj\u00f6rk","year":"2009","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117484_b0085","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.33493","volume":"64","author":"Bengtsson","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-021-02573-0","article-title":"An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod","volume":"23","author":"Hesselstrand","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0095","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1038\/s41598-023-42763-1","article-title":"Generation of a familial hypercholesterolemia model in non-human primate","volume":"13","author":"Sato","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5625\/lar.2016.32.1.46","article-title":"Reference values of hematology, biochemistry, and blood type in cynomolgus monkeys from cambodia origin","volume":"32","author":"Choi","year":"2016","journal-title":"Lab. Anim. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1399-3089.2004.00186.x","article-title":"Reference values for clinical chemistry and clinical hematology parameters in cynomolgus monkeys","volume":"12","author":"Schuurman","year":"2005","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.bcp.2025.117484_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/853916","article-title":"Uncovering the complexity of transcriptomes with RNA-Seq","volume":"2010","author":"Costa","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117484_b0115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.bcp.2025.117484_b0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.116.07357","article-title":"Novel therapeutic role for dipeptidyl peptidase III in the treatment of hypertension","volume":"68","author":"Pang","year":"2016","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.bcp.2025.117484_b0130","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/ATVBAHA.125.322619","article-title":"Afadin promotes vascular smooth muscle cell contraction by interacting with phospholipase C to enhance Ca2+ signaling for blood pressure regulation","volume":"45","author":"Khan","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117484_b0135","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2133\/dmpk.DMPK-10-NT-101","article-title":"Regional distribution of drug-metabolizing enzyme activities in the liver and small intestine of cynomolgus monkeys","volume":"26","author":"Nakanishi","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2025.117484_b0140","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117484_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/828354","article-title":"S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease","volume":"2013","author":"Schiopu","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"13","key":"10.1016\/j.bcp.2025.117484_b0150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","article-title":"Neutrophil-derived S100A8\/A9 amplify granulopoiesis after myocardial infarction","volume":"141","author":"Sreejit","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117484_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.587149","article-title":"The effects of repeat-dose doxorubicin on cardiovascular functional endpoints and biomarkers in the telemetry-equipped cynomolgus monkey","volume":"8","author":"Engwall","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12964-023-01077-5","article-title":"Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2025.117484_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.670479","article-title":"Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician","volume":"12","author":"Podyacheva","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117484_b0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cvr\/cvx246","article-title":"Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research","volume":"114","author":"Lipshultz","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117484_b0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11897-020-00489-5","article-title":"Anthracycline-related heart failure: certain knowledge and open questions: where do we stand with chemotherapyinduced cardiotoxicity?","volume":"17","author":"Robinson","year":"2020","journal-title":"Curr. Heart Fail. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2025.117484_b0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2183\/pjab.84.176","article-title":"Chemical carcinogenesis studies in nonhuman primates","volume":"84","author":"Takayama","year":"2008","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117484_b0185","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/biom12060859","article-title":"Comparative study of transcriptome in the hearts isolated from mice, rats, and humans","volume":"12","author":"Okada","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2025.117484_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108308","article-title":"Developmental gene expression differences between humans and mammalian models","volume":"33","author":"Cardoso-Moreira","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.117484_b0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/ATVBAHA.111.236927","article-title":"S100A8 and S100A9 in cardiovascular biology and disease","volume":"32","author":"Averill","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"50","key":"10.1016\/j.bcp.2025.117484_b0200","doi-asserted-by":"crossref","first-page":"41521","DOI":"10.1074\/jbc.M509442200","article-title":"S100A8 and S100A9 in human arterial wall. Implications for atherogenesis","volume":"280","author":"McCormick","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2025.117484_b0205","doi-asserted-by":"crossref","first-page":"22665","DOI":"10.1074\/jbc.M110.202135","article-title":"Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8\/A9 proteins","volume":"286","author":"Farris","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2013.02.023","article-title":"Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE nullmice","volume":"228","author":"Yan","year":"2013","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.bcp.2025.117484_b0215","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI92450","article-title":"Neutrophil-derived S100 calcium-binding proteins A8\/A9 promote reticulated thrombocytosis and atherogenesis in diabetes","volume":"127","author":"Kraakman","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bcp.2025.117484_b0220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","article-title":"S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury","volume":"140","author":"Li","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bcp.2025.117484_b0225","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/HYPERTENSIONAHA.113.02843","article-title":"S100a8\/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury","volume":"63","author":"Wu","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.117484_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109716","article-title":"S100a8\/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1\/2-Drp1-mediated mitochondrial fission and respiratory dysfunction","volume":"115","author":"Wu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117484_b0235","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCRESAHA.122.321504","article-title":"Ponatinib drives cardiotoxicity by S100A8\/A9-NLRP3-IL-1\u03b2 mediated inflammation","volume":"132","author":"Tousif","year":"2023","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117484_b0240","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1634\/theoncologist.2015-0253","article-title":"Ponatinib: accelerated disapproval","volume":"20","author":"Gainor","year":"2015","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.bcp.2025.117484_b0245","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0028-3908(02)00015-1","article-title":"Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1\/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue","volume":"42","author":"Zou","year":"2002","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.bcp.2025.117484_b0250","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/pros.20509","article-title":"Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer","volume":"66","author":"Isaacs","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2025.117484_b0255","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2147\/DDDT.S55308","article-title":"Laquinimod in the treatment of multiple sclerosis: a review of the data so far","volume":"10","author":"Th\u00f6ne","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2025.117484_b0260","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","article-title":"Placebo-controlled trial of oral laquinimod for multiple sclerosis","volume":"366","author":"Comi","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.bcp.2025.117484_b0265","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2016.66.9697","article-title":"Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer","volume":"34","author":"Sternberg","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117484_b0270","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-12-2730","article-title":"Tasquinimod is an allosteric modulator of HDAC4 survival signaling within the compromised cancer microenvironment","volume":"73","author":"Isaacs","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1756287215603558","article-title":"Tasquinimod in the treatment of castrate-resistant prostate cancer \u2013 current status and future prospects","volume":"8","author":"Mehta","year":"2016","journal-title":"Ther. Adv. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117484_b0280","doi-asserted-by":"crossref","first-page":"23574","DOI":"10.1038\/s41598-024-74695-9","article-title":"The role of the S100A8\/S100A9 in gastric tumor progression","volume":"14","author":"Fang","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2025.117484_b0285","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11596-025-00042-2","article-title":"Targeting calprotectin S100A8\/A9 to overcome AML progression in DNMT3A-mutant cells","volume":"45","author":"Cai","year":"2025","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.bcp.2025.117484_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1479502","article-title":"Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity","volume":"15","author":"Demir","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500749X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500749X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:56:54Z","timestamp":1775797014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500749X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":58,"alternative-id":["S000629522500749X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117484","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of the neutrophil-derived S100A8\/A9 complex ameliorates doxorubicin-induced cardiomyopathy in non-human primates","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117484"}}